v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
ASSETS    
Cash $ 1,728 $ 3,013
Restricted cash 2,052 1,631
Accounts receivable, net of allowances of $1,057 and $727 10,294 8,025
Inventory 1,520 1,354
Notes receivable 594 644
Prepaid expenses and other 1,532 1,623
Total current assets 17,720 16,290
Property and equipment, net 35,189 35,805
Assets held for sale, net 4,251 4,207
Restricted cash 796 1,420
Intangible assets 4,607 4,660
Other assets 3,815 3,842
Goodwill [1] 1,585 1,585
Total assets 67,963 67,809
LIABILITIES AND EQUITY (DEFICIT)    
Accounts payable 7,337 6,986
Accrued expenses 9,329 7,888
Other liabilities 1,982 867
Debt related to assets held for sale, net 3,072 3,001
Current portion of long term debt 5,366 5,414
Total current liabilities 27,086 24,156
Long-term debt, net - less current maturities 34,123 34,738
Operating lease obligation 2,276 2,325
Other liabilities 1,499 1,550
Total liabilities 64,984 62,769
Stockholders' equity:    
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,936 issued and 3,925 outstanding at June 30, 2026 and 3,946 issued and 3,935 outstanding at December 31, 2025. 67,465 67,296
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately    
Accumulated deficit (83,716) (81,777)
Accumulated other comprehensive earnings 22 22
Total stockholders' equity (deficit) (1,712) 349
Total liabilities, Series D preferred stock and stockholders' equity (deficit) 67,963 67,809
Series D Preferred Stock    
LIABILITIES AND EQUITY (DEFICIT)    
Preferred stock, Series D, no par values, 1,420 shares authorized; 1,405 shares issued and outstanding at June 30, 2026 and December 31, 2025. 4,691 4,691
Series A Preferred Stock    
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately    
Preferred stock 426 426
Series B Preferred Stock    
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A, Series B and Series D); shares issued and outstanding designated separately    
Preferred stock $ 14,091 $ 14,382
[1] The Company does not amortize indefinite-lived intangibles, which consist of separable bed licenses and goodwill